Literature DB >> 23665371

Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reporting.

Bhuvnesh Aggarwal1, Stephen G Ellis, A Michael Lincoff, Samir R Kapadia, Joseph Cacchione, Russell E Raymond, Leslie Cho, Christopher Bajzer, Ravi Nair, Irving Franco, Conrad Simpfendorfer, E Murat Tuzcu, Patrick L Whitlow, Mehdi H Shishehbor.   

Abstract

OBJECTIVES: This study sought to ascertain causes of death and the incidence of percutaneous coronary intervention (PCI)-related mortality within 30 days.
BACKGROUND: Public reporting of 30-day mortality after PCI without clearly identifying the cause may result in operator risk avoidance and affect hospital reputation and reimbursements. Death certificates, utilized by previous reports, have poor correlation with actual cause of death and may be inadequate for public reporting.
METHODS: All patients who died within 30 days of a PCI from January 2009 to April 2011 at a tertiary care center were included. Causes of death were identified through detailed chart review using Academic Research Consortium consensus guidelines and compared with reported death certificates. The causes of death were divided into cardiac and noncardiac and PCI and non-PCI-related categories.
RESULTS: Of the 4,078 PCI, 81 deaths (2%) occurred within 30 days. Of these, 58% died of cardiac and 42% of noncardiac causes. However, only 42% of 30-day deaths were attributed to PCI-related complications. Patients with non-PCI-related, compared with PCI-related, death presented with a higher incidence of cardiogenic shock (15 of 47 [32%] vs. 2 of 34 [6%]; p < 0.01) and cardiac arrest (19 of 47 [40%] vs. 1 of 34 [3%]; p < 0.01). Death certificates had only 58% accuracy (95% confidence interval: 45% to 72%) for classifying patients as experiencing cardiac versus noncardiac death.
CONCLUSIONS: Less than one-half of 30-day deaths are attributed to a PCI-related complication. Death certificates are inaccurate and do not report PCI-related deaths, which may represent a better marker of PCI quality.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ARC; Academic Research Consortium; CI; GI; PCI; ST-segment elevation myocardial infarction; STEMI; cause of death; confidence interval; coronary intervention; gastrointestinal; mortality; outcomes; percutaneous coronary intervention; public reporting; risk avoidance

Mesh:

Year:  2013        PMID: 23665371     DOI: 10.1016/j.jacc.2013.03.071

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

1.  A case of ventricular septal rupture associated with major septal branch occlusion after percutaneous coronary intervention.

Authors:  Toru Yoshizaki; Marina Ishida; Tamotsu Takagi; Gaku Matsukura; Satoshi Yamashita; Natsuko Hosoya; Shigetaka Kageyama; Yuzo Watanabe; Ryosuke Takeuchi; Koichiro Murata; Ryuzo Nawada; Tomoya Onodera; Masanao Nakai
Journal:  J Cardiol Cases       Date:  2014-07-17

Review 2.  Public reporting of PCI outcomes: for better or for worse.

Authors:  Brian J Potter; Robert W Yeh; Duane S Pinto
Journal:  Curr Cardiol Rep       Date:  2014-07       Impact factor: 2.931

3.  Causes of death and predictors of survival after aortic valve replacement in low flow vs. normal flow severe aortic stenosis with preserved ejection fraction.

Authors:  Mackram F Eleid; Hector I Michelena; Vuyisile T Nkomo; Rick A Nishimura; Joseph F Malouf; Christopher G Scott; Patricia A Pellikka
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-04-20       Impact factor: 6.875

4.  2016 Revision of the SCAI position statement on public reporting.

Authors:  Lloyd W Klein; Kishore J Harjai; Fred Resnic; William S Weintraub; H Vernon Anderson; Robert W Yeh; Dmitriy N Feldman; Osvaldo S Gigliotti; Kenneth Rosenfeld; Peter Duffy
Journal:  Catheter Cardiovasc Interv       Date:  2016-11-10       Impact factor: 2.692

5.  Risk factors and clinical characteristics of in-hospital death in acute myocardial infarction with IABP support.

Authors:  Jianing Cao; Wenxian Liu; Jiajia Zhu; Han Zhao
Journal:  Int J Clin Exp Med       Date:  2015-05-15

6.  Factors associated with performing urgent coronary angiography in out-of-hospital cardiac arrest patients.

Authors:  David H Lam; Lauren M Glassmoyer; Jordan B Strom; Roger B Davis; James M McCabe; Donald E Cutlip; Michael W Donnino; Michael N Cocchi; Duane S Pinto
Journal:  Catheter Cardiovasc Interv       Date:  2017-08-02       Impact factor: 2.692

7.  Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis.

Authors:  Mario Gaudino; Irbaz Hameed; Michael E Farkouh; Mohamed Rahouma; Ajita Naik; N Bryce Robinson; Yongle Ruan; Michelle Demetres; Giuseppe Biondi-Zoccai; Dominick J Angiolillo; Emilia Bagiella; Mary E Charlson; Umberto Benedetto; Marc Ruel; David P Taggart; Leonard N Girardi; Deepak L Bhatt; Stephen E Fremes
Journal:  JAMA Intern Med       Date:  2020-12-01       Impact factor: 21.873

8.  Mortality Following Pediatric Congenital Heart Surgery: An Analysis of the Causes of Death Derived From the National Death Index.

Authors:  Courtney McCracken; Logan G Spector; Jeremiah S Menk; Jessica H Knight; Jeffrey M Vinocur; Amanda S Thomas; Matthew E Oster; James D St Louis; James H Moller; Lazaros Kochilas
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

9.  An Australian longitudinal pilot study examining health determinants of cardiac outcomes 12 months post percutaneous coronary intervention.

Authors:  Karen-Leigh Edward; John Stephenson; Jo-Ann Giandinoto; Andrew Wilson; Robert Whitbourn; Jack Gutman; Andrew Newcomb
Journal:  BMC Cardiovasc Disord       Date:  2016-02-03       Impact factor: 2.298

10.  Thrombotic/Thrombolytic Balance as a Cardiac Treatment Determinant in Patients With Diabetes Mellitus and Coronary Artery Disease.

Authors:  Tetsuro Tsujimoto; Hiroshi Kajio
Journal:  J Am Heart Assoc       Date:  2019-01-22       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.